11 – 20 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
- Contribution to journal › Scientific review
-
Mark
Right ventricular stroke work index from echocardiography in patients with pulmonary arterial hypertension-the role in short-term follow-up assessment
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation : The Results of a Randomized Controlled Trial (SCHEDULE Trial)
- Contribution to journal › Article
-
Mark
Risk stratification and treatment goals in pulmonary arterial hypertension
- Contribution to journal › Scientific review
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
- Contribution to journal › Article
-
Mark
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
- Contribution to journal › Article
- 2023
-
Mark
Evaluation of the European Society of Cardiology/European Respiratory Society derived three-and four-strata risk stratification models in pulmonary arterial hypertension : Introducing an internet-based risk stratification calculator
- Contribution to journal › Article
-
Mark
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
- Contribution to journal › Article
-
Mark
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- Contribution to journal › Article
